95 related articles for article (PubMed ID: 16954943)
1. 18Fluoro-deoxyglucose positron emission tomography evaluation of benign versus malignant osteochondromas: preliminary observations.
Feldman F; Vanheertum R; Saxena C
J Comput Assist Tomogr; 2006; 30(5):858-64. PubMed ID: 16954943
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography/computed tomography with 18fluoro-deoxyglucose in the detection of local recurrence and distant metastases of pediatric sarcoma.
Arush MW; Israel O; Postovsky S; Militianu D; Meller I; Zaidman I; Sapir AE; Bar-Shalom R
Pediatr Blood Cancer; 2007 Dec; 49(7):901-5. PubMed ID: 17252575
[TBL] [Abstract][Full Text] [Related]
3. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
[TBL] [Abstract][Full Text] [Related]
4. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
5. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
6. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
7. 18FDG-PET applications for cartilage neoplasms.
Feldman F; Van Heertum R; Saxena C; Parisien M
Skeletal Radiol; 2005 Jul; 34(7):367-74. PubMed ID: 15937711
[TBL] [Abstract][Full Text] [Related]
8. Objective and subjective comparison of standard 2-D and fully 3-D reconstructed data on a PET/CT system.
Strobel K; Rüdy M; Treyer V; Veit-Haibach P; Burger C; Hany TF
Nucl Med Commun; 2007 Jul; 28(7):555-9. PubMed ID: 17538397
[TBL] [Abstract][Full Text] [Related]
9. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care.
Gordin A; Golz A; Keidar Z; Daitzchman M; Bar-Shalom R; Israel O
Otolaryngol Head Neck Surg; 2007 Jul; 137(1):130-7. PubMed ID: 17599580
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of a breath-holding acquisition method in PET/CT for pulmonary lesions.
Yamaguchi T; Ueda O; Hara H; Sakai H; Kida T; Suzuki K; Adachi S; Ishii K
Ann Nucl Med; 2009 Jan; 23(1):65-71. PubMed ID: 19205840
[TBL] [Abstract][Full Text] [Related]
11. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
12. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas.
Iagaru A; Quon A; McDougall IR; Gambhir SS
Clin Nucl Med; 2006 Dec; 31(12):754-60. PubMed ID: 17117068
[TBL] [Abstract][Full Text] [Related]
13. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
[TBL] [Abstract][Full Text] [Related]
14. Preliminary clinical applications of a device-dedicated whole-body positron emission tomography reconstruction method: impact on standardized uptake values.
Daouk J; Bailly P; Fin L; Meyer ME
Nucl Med Commun; 2010 Sep; 31(9):793-9. PubMed ID: 20634766
[TBL] [Abstract][Full Text] [Related]
15. 18FDG PET scanning of benign and malignant musculoskeletal lesions.
Feldman F; van Heertum R; Manos C
Skeletal Radiol; 2003 Apr; 32(4):201-8. PubMed ID: 12652335
[TBL] [Abstract][Full Text] [Related]
16. Integrated PET/CT in evaluating sarcomatous transformation in osteochondromas.
Purandare NC; Rangarajan V; Agarwal M; Sharma AR; Shah S; Arora A; Parasar DS
Clin Nucl Med; 2009 Jun; 34(6):350-4. PubMed ID: 19487843
[TBL] [Abstract][Full Text] [Related]
17. Improved differentiation of benign osteochondromas from secondary chondrosarcomas with standardized measurement of cartilage cap at CT and MR imaging.
Bernard SA; Murphey MD; Flemming DJ; Kransdorf MJ
Radiology; 2010 Jun; 255(3):857-65. PubMed ID: 20392983
[TBL] [Abstract][Full Text] [Related]
18. [Osteochondroma and multiple osteochondromas: recommendations on the diagnostics and follow-up with special consideration to the occurrence of secondary chondrosarcoma].
Herget GW; Kontny U; Saueressig U; Baumhoer D; Hauschild O; Elger T; Südkamp NP; Uhl M
Radiologe; 2013 Dec; 53(12):1125-36. PubMed ID: 24129968
[TBL] [Abstract][Full Text] [Related]
19. Manifestations and management of osteochondromas: a retrospective analysis of 382 patients.
Saglik Y; Altay M; Unal VS; Basarir K; Yildiz Y
Acta Orthop Belg; 2006 Dec; 72(6):748-55. PubMed ID: 17260614
[TBL] [Abstract][Full Text] [Related]
20. EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis.
Bovée JV; Hameetman L; Kroon HM; Aigner T; Hogendoorn PC
J Pathol; 2006 Jul; 209(3):411-9. PubMed ID: 16622899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]